BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3401579)

  • 21. [Pharmacokinetic, behavioral and neurophysiological aspects of the action of 2-ethyl-6-methyl-3-hydroxypyridine in rats].
    Sariev AK; Krapivin SV; Voronina TA; Zherdev VP
    Biull Eksp Biol Med; 1988 Aug; 106(8):165-7. PubMed ID: 3416050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The functional-morphological characteristics of alcohol-induced pathology as dependent on the nature of the intoxication and its nootropil correction in an experiment].
    Sidorov PI; Gromova LE; Solov'ev AG; Degteva GN; Leont'ev VIa; Savastenko AE
    Patol Fiziol Eksp Ter; 2000; (3):17-9. PubMed ID: 10983474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous investigation of the cerebral circulation and cortical bioelectrical activity in dogs under the influence of piracetam.
    Nikolova M; Tsikalova R; Nikolov R; Taskov M
    Methods Find Exp Clin Pharmacol; 1979 Jun; 1(2):97-104. PubMed ID: 552587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam.
    Petkov VD; Grahovska T; Petkov VV; Konstantinova E; Stancheva S
    Acta Physiol Pharmacol Bulg; 1984; 10(4):6-15. PubMed ID: 6535371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of preparations from the nootropic group for treating memory disorders in chronic alcoholism].
    Shabanov PD; Grinenko AIa; Kalishevich SIu
    Klin Med (Mosk); 1988 Sep; 66(9):114-6. PubMed ID: 3204950
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of nootropil on oxidative phosphorylation in the brain of rats with ischemic myocardial necrosis].
    Davydov VV; Iakushev VS
    Farmakol Toksikol; 1987; 50(2):99-100. PubMed ID: 3582646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic ethanol inhibits inositol metabolism in specific brain regions.
    Zhang JP; Xia JM; Sun GY
    Alcohol Clin Exp Res; 1997 Jun; 21(4):716-20. PubMed ID: 9194929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of piracetam on nonesterified fatty acids (NEFA) in rat brain during insulin hypoglycemia.
    Sklenovský A; Chmela Z
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():63-70. PubMed ID: 6242672
    [No Abstract]   [Full Text] [Related]  

  • 30. [Morphometric analysis of the changes in the cerebral cortex of rats after long-term administration of alcohol].
    Khokhrina NT; Kazakova PB; Rakhmanova VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):66-7. PubMed ID: 1665657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The brain electrical processes in dominant alcoholic motivation in rats].
    Batuev AS; Stankevich AS; Aleksandrov AA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(6):1086-96. PubMed ID: 7879432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental electroencephalographic study of piracetam in cats.
    Nikolova M
    Methods Find Exp Clin Pharmacol; 1981; 3(6):367-75. PubMed ID: 7329161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of Piracetam on the mental functional capacity of chronic alcoholics (author's transl)].
    Binder S; Doddabela P
    Med Klin; 1976 Apr; 71(17):711-6. PubMed ID: 775275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of nootropic agents on serum biochemical indices in intellectually deficient children].
    Turova NF; Ermolina LA; Baryshnikov VA; Kopaladze RA; Aziavchik AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1558-63. PubMed ID: 6686404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam.
    Pietrzak B; Czarnecka E
    Alcohol; 2008 Mar; 42(2):115-22. PubMed ID: 18358990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropharmacological properties of piracetam derivatives].
    Ostrovskaia RU; Molodavkin GM; Trofimov SS; Popova RIa; Gudasheva TA
    Biull Eksp Biol Med; 1982 Dec; 94(12):62-5. PubMed ID: 6891272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurophysiologic and pathomorphologic characteristics of the development of alcoholism (experimental study)].
    Vorob'eva TM; Gordienko ZhP; Paĭkova LN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):77-84. PubMed ID: 2160177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The protective effect of piracetam during delivery].
    Klink F; Grosspietzsch R; von Klitzing L; Oberheuser F
    Fortschr Med; 1979 Dec; 97(46):2163-5. PubMed ID: 535860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [GABA-ergic cortical component in the action of piracetam and cetyl GABA].
    Ostrovskaia RU; Molodavkin GM; Kovalev GI
    Biull Eksp Biol Med; 1982 Apr; 93(4):62-4. PubMed ID: 7082805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of ethanol intake and withdrawal on penicillin-induced epileptiform activity in rats.
    Kozan R; Ayyildiz M; Yildirim M; Agar E
    Brain Res Bull; 2006 Dec; 71(1-3):111-5. PubMed ID: 17113936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.